169 related articles for article (PubMed ID: 15784806)
1. Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.
Lam MS; Sims-McCallum RP
Ann Pharmacother; 2005 May; 39(5):885-91. PubMed ID: 15784806
[TBL] [Abstract][Full Text] [Related]
2. Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Poon MC
Curr Hematol Rep; 2003 Mar; 2(2):139-47. PubMed ID: 12901145
[TBL] [Abstract][Full Text] [Related]
3. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa in the treatment of bleeding.
Midathada MV; Mehta P; Waner M; Fink LM
Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
[TBL] [Abstract][Full Text] [Related]
5. Update on Novo Nordisk's clinical trial programme on NovoSeven.
Dejgaard A
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S39-41. PubMed ID: 14567535
[TBL] [Abstract][Full Text] [Related]
6. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Levi M; Peters M; Büller HR
Crit Care Med; 2005 Apr; 33(4):883-90. PubMed ID: 15818119
[TBL] [Abstract][Full Text] [Related]
8. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective.
Vincent JL; Rossaint R; Riou B; Ozier Y; Zideman D; Spahn DR
Crit Care; 2006; 10(4):R120. PubMed ID: 16919168
[TBL] [Abstract][Full Text] [Related]
9. Ongoing NovoSeven trials.
Erhardtsen E
Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
[TBL] [Abstract][Full Text] [Related]
10. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
11. Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
[TBL] [Abstract][Full Text] [Related]
12. Recombinant activated factor VII for non-hemophiliac bleeding patients.
Uhlmann EJ; Eby CS
Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures.
Krisl JC; Meadows HE; Greenberg CS; Mazur JE
Ann Pharmacother; 2011 Nov; 45(11):1433-8. PubMed ID: 22009992
[TBL] [Abstract][Full Text] [Related]
14. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.
Mohr AM; Holcomb JB; Dutton RP; Duranteau J
Crit Care; 2005; 9 Suppl 5(Suppl 5):S37-42. PubMed ID: 16221318
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based Emergency Medicine/Critically Appraised Topic. The efficacy of recombinant activated factor VII in severe trauma.
Nishijima DK; Zehtabchi S
Ann Emerg Med; 2009 Nov; 54(5):737-744.e1. PubMed ID: 19285753
[TBL] [Abstract][Full Text] [Related]
17. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients.
AlGahtani FH; Alshaikh M; AlDiab A
Ann Saudi Med; 2010; 30(3):198-202. PubMed ID: 20427935
[TBL] [Abstract][Full Text] [Related]
20. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Selin S; Tejani A
Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
